Yale Program in Addiction Medicine
@yaleadm
No wrong door. Improving access to & effectiveness of prevention, treatment, & harm reduction services for people who use substances & those with addiction.
ID: 1169994069940080641
https://medicine.yale.edu/intmed/genmed/addictionmedicine/ 06-09-2019 15:21:48
2,2K Tweet
3,3K Followers
452 Following
In July, The SASH Lab at Yale brought 200+ students to New Haven for a community forum on youth substance use in urban communities. The forum, shares Dr. Ijeoma Opara, "exemplifies the power of using youth and community voices to drive substance use prevention." medicine.yale.edu/news-article/c…
🚨 New paper: Thrilled to share our latest review in the Journal of #Addiction Medicine on the impact of #fentanyl on pharmacotherapies for #OpioidUseDisorder. Co-first authored with Olúwolé Jegede MD, MPH and in collaboration with colleagues at Yale Psychiatry. shorturl.at/inzuO
Ep. #29: Hallucinogens with Dr. Al Garcia-Romeu , hosted by Katherine Mullins MD, AAHIVS, Shawn Cohen . We cover what clinicians should know about hallucinogens! American College of Academic Addiction Medicine 💫Hallucinogen types 🗒️Psychedelic Assisted Therapy 📢Risks, benefits, + more! Listen thecurbsiders.com/addiction
Prof. Dr. Ijeoma Opara, director of The SASH Lab at Yale, held the lab's first community forum July 25 at Yale New Haven Hospital's Fitkin Amphitheater. It brought together over 200 youth, parents, and health officials from New Jersey and Boston. Learn more ⬇️ ow.ly/CYos50SUWjQ
For pregnant ppl w/ OUD, buprenorphine + naloxone together were associated w/ similar or better neonatal & maternal outcomes v. buprenorphine alone, a large nationwide population-based cohort study found. Gail D'Onofrio & others weigh in for MedPage Today: medpagetoday.com/psychiatry/add…
Call for abstracts and registration for Yale Conference for Alcohol Research & Education! Abstract submission & registration link below! Bubu Banini, MD PhD Yale Psychiatry Yale Internal Medicine Yale Program in Addiction Medicine 🔗⬇️ medicine.yale.edu/internal-medic…
Yale Program in Addiction Medicine Weekly Update | Week of August 19th 🔗view.message.yale.edu/?qs=54071b0868…
September is fast approaching and we're looking forward to the 8th Annual Schottenfeld Lecture with guest speaker, Dr. Jeffrey Samet (BU Medical BMC Addiction Medicine Fellowship)! We hope to see you there, in-person or online! 🔗yalesurvey.ca1.qualtrics.com/jfe/form/SV_1T…
Yale Program in Addiction Medicine Weekly Update | Week of August 26th 🔗view.message.yale.edu/?qs=1ec3b1a1c2…
Buprenorphine for Opioid Use Disorder—An Essential Medical Treatment | Substance Use and Addiction Medicine | JAMA Internal Medicine | JAMA Network JAMA Internal Medicine Yale School of Medicine Yale Program in Addiction Medicine jamanetwork.com/journals/jamai…
Yale Program in Addiction Medicine Weekly Update | Week of September 3rd 🔗view.message.yale.edu/?qs=cbc8bbd2bb…
#ISAM2024 kicks off, tomorrow, in #Istanbul! Will you be attending? Don't miss your chance to hear from Yale School of Medicine Yale School of Public Health faculty, staff, & collaborators presenting at this year's proceedings! Presentation dates, times, & locations below:
The overdose crisis is evolving and stimulant-involved deaths on the rise. In a recent JAMA Psychiatry viewpoint, Drs. Ben Howell, Lewei (Allison) Lin, & Lara Coughlin outline recs to advance treatment of co-occurring stimulant & opioid use disorders. jamanetwork.com/journals/jamap…
Oops! We missed a presentation in our #ISAM2024 schedule. Updated graphic below ⬇️ If you're at the conference, catch "Improving Outcomes & Mortality from Fentanyl - Split Dose, Toxicology, & Breastfeeding" from Dr. Sharon Ostfeld-Johns (Yale Pediatrics) & team today (9/6)!
Honored to present a workshop on Substance Use in LGBTQ Populations with Cara Borelli at #ISAM2024 in Istanbul! Yale Program in Addiction Medicine ISAMAddiction Yale School of Public Health Yale School of Medicine